Registration is Now Closed
Registration is now closed. Thank you to our speakers, sponsors and delegates for joining us!
Register your interest to be the first to hear updates about the 2025 meeting.
RNA Therapy
Delivering Safe & Effective RNA Therapies & Vaccines to Patients Faster
Conferences
From mRNA to RNA editing. From RNAi to small molecules targeting RNA. Our niche and definitive conferences focus purely on advancing RNA-based therapies to market.
DataÂ
Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space including oligonucleotide-based therapies, mRNA-based therapies, ribozyme therapies, gRNA-mediated gene editing therapies and RNA-targeted small molecules.
Market Research
A trusted provider of market intelligence for anyone looking to understand the complexities of RNA therapy research and development.
Top 3 Reasons To Register Interest for 2025
Explore the transformative potential of LNP delivery systems in transporting complex payloads such as oligonucleotides, DNA, large peptides, and gene editors, expanding therapeutic modalities. Through this exploration, discover precise and efficient delivery mechanisms that enhance the transportation of these payloads, ultimately leading to improved patient outcomes.
Achieve extrahepatic delivery with assurance, targeting tissues including the muscles, lungs, eyes, spleen,
and beyond, tailored to your therapeutic application. Overcome biological barriers associated with these tissues for enhanced efficacy and precision.
Explore the strategic utilization of small molecule ligands and antibody fragments to enhance targeted drug delivery,paving the way for advancements in therapeutic precision and efficacy.
Discounted rates are available for full time academics & Not-for-Profit organizations. Please email us at info@hansonwade.com for more information.